Duncker Streett & Co’s Gilead Sciences GILD Stock Holding History

Duncker Streett & Co’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-150	Closed	-$10.3K	–	493
2024 Q2	$10.3K	Sell	150 -400	-73%	-$26.7K	﹤0.01%	412
2024 Q1	$40.3K	Hold	550	–	–	0.01%	331
2023 Q4	$44.6K	Hold	550	–	–	0.01%	321
2023 Q3	$41.2K	Hold	550	–	–	0.01%	318
2023 Q2	$42.4K	Hold	550	–	–	0.01%	313
2023 Q1	$45.6K	Hold	550	–	–	0.01%	304
2022 Q4	$47.2K	Buy	550 +400	+267%	+$31.7K	0.01%	307
2022 Q3	$9K	Hold	150	–	–	﹤0.01%	398
2022 Q2	$9K	Hold	150	–	–	﹤0.01%	407
2022 Q1	$9K	Sell	150 -300	-67%	-$19.2K	﹤0.01%	414
2021 Q4	$33K	Hold	450	–	–	0.01%	372
2021 Q3	$31K	Sell	450 -475	-51%	-$33.4K	0.01%	368
2021 Q2	$64K	Sell	925 -300	-24%	-$20K	0.01%	318
2021 Q1	$79K	Sell	1,225 -1,150	-48%	-$74.2K	0.02%	302
2020 Q4	$138K	Sell	2,375 -650	-21%	-$39.2K	0.03%	259
2020 Q3	$191K	Hold	3,025	–	–	0.04%	227
2020 Q2	$233K	Sell	3,025 -300	-9%	-$23K	0.06%	217
2020 Q1	$249K	Buy	3,325 +76	+2%	+$5.25K	0.07%	210
2019 Q4	$211K	Sell	3,249 -1,321	-29%	-$86K	0.04%	245
2019 Q3	$290K	Buy	4,570 +502	+12%	+$32.8K	0.07%	226
2019 Q2	$275K	Sell	4,068 -597	-13%	-$39.3K	0.06%	235
2019 Q1	$303K	Buy	4,665 +2	+0%	+$133	0.07%	226
2018 Q4	$292K	Sell	4,663 -598	-11%	-$41.8K	0.08%	212
2018 Q3	$406K	Sell	5,261 -228	-4%	-$17.2K	0.09%	202
2018 Q2	$389K	Buy	5,489 +3	+0.1%	+$212	0.1%	197
2018 Q1	$414K	Buy	5,486 +1,100	+25%	+$87.4K	0.1%	192
2017 Q4	$314K	Sell	4,386 -930	-17%	-$70.6K	0.08%	226
2017 Q3	$431K	Buy	5,316 +2,079	+64%	+$159K	0.13%	181
2017 Q2	$229K	Buy	3,237 +330	+11%	+$22K	0.07%	237
2017 Q1	$197K	Sell	2,907 -456	-14%	-$32.1K	0.06%	249
2016 Q4	$241K	Sell	3,363 -996	-23%	-$74K	0.08%	230
2016 Q3	$345K	Sell	4,359 -167	-4%	-$13.6K	0.12%	180
2016 Q2	$378K	Buy	4,526 +1	+0%	+$89	0.13%	172
2016 Q1	$416K	Buy	4,525 +450	+11%	+$40.6K	0.15%	154
2015 Q4	$412K	Sell	4,075 -590	-13%	-$61.4K	0.15%	150
2015 Q3	$458K	Buy	4,665 +710	+18%	+$78.9K	0.18%	138
2015 Q2	$463K	Sell	3,955 -300	-7%	-$32.8K	0.16%	150
2015 Q1	$418K	Hold	4,255	–	–	0.14%	172
2014 Q4	$401K	Buy	4,255 +650	+18%	+$67.2K	0.13%	175
2014 Q3	$384K	Buy	3,605 +400	+12%	+$39.2K	0.13%	180
2014 Q2	$266K	Buy	3,205 +2,755	+612%	+$214K	0.09%	229
2014 Q1	$32K	Buy	+450	New	+$35.3K	0.01%	414

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Duncker Streett & Co's GILD Position: Q3 2024 in Review

Duncker Streett & Co sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 150 shares — an estimated $10.3K sold.

Duncker Streett & Co first reported a position in GILD in Q1 2014 and held it in 42 quarters. The position peaked at $463K in Q2 2015. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

Duncker Streett & Co reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
Duncker Streett & Co sold 150 Gilead Sciences shares in Q3 2024, an estimated $10.3K.
Duncker Streett & Co first reported a position in Gilead Sciences in Q1 2014 and held it in 42 quarters.
Duncker Streett & Co's Gilead Sciences position peaked at $463K in Q2 2015.
1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Duncker Streett & Co's 13F filing for Q3 2024, filed 12 Nov 2024.